Institutional investors purchased a net $6.1 million shares of MNKD during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 23.39% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL FUND MANAGEMENT SA Bought 1.6 Million shares of Mannkind Corp
PROSHARE ADVISORS LLC Bought 24.8 Thousand shares of Mannkind Corp
PROFUND ADVISORS LLC Bought 19.3 Thousand shares of Mannkind Corp